| Primary |
| Product Used For Unknown Indication |
20.1% |
| Drug Use For Unknown Indication |
18.4% |
| Rheumatoid Arthritis |
15.6% |
| Ankylosing Spondylitis |
14.5% |
| Pain |
4.5% |
| Abdominal Pain |
3.4% |
| Arthralgia |
2.8% |
| Juvenile Idiopathic Arthritis |
2.8% |
| Back Pain |
2.2% |
| Hepatitis C |
2.2% |
| Migraine |
2.2% |
| Contraception |
1.7% |
| Musculoskeletal Pain |
1.7% |
| Sciatica |
1.7% |
| Diabetes Mellitus |
1.1% |
| Diarrhoea |
1.1% |
| Oedema Peripheral |
1.1% |
| Polymorphic Light Eruption |
1.1% |
| Torticollis |
1.1% |
| Acne |
0.6% |
|
| Renal Failure Acute |
15.2% |
| Thrombocytopenia |
10.9% |
| Neuropathy Peripheral |
8.7% |
| Drug Toxicity |
6.5% |
| Histiocytosis Haematophagic |
6.5% |
| Intra-uterine Death |
6.5% |
| Drug Intolerance |
4.3% |
| Enterocolitis Infectious |
4.3% |
| Jaundice |
4.3% |
| Pyrexia |
4.3% |
| Shock |
4.3% |
| Thrombocytopenic Purpura |
4.3% |
| Vertigo |
4.3% |
| Anaemia |
2.2% |
| Bone Marrow Failure |
2.2% |
| Cellulitis |
2.2% |
| Cellulitis Staphylococcal |
2.2% |
| Congestive Cardiomyopathy |
2.2% |
| Depression |
2.2% |
| Dermo-hypodermitis |
2.2% |
|
| Secondary |
| Rheumatoid Arthritis |
23.9% |
| Product Used For Unknown Indication |
16.6% |
| Drug Use For Unknown Indication |
10.8% |
| Ankylosing Spondylitis |
9.3% |
| Pain |
6.2% |
| Ill-defined Disorder |
4.2% |
| Back Pain |
3.1% |
| Headache |
3.1% |
| Tooth Extraction |
3.1% |
| Sciatica |
2.7% |
| Pain Management |
2.3% |
| Pharyngitis |
1.9% |
| Suicide Attempt |
1.9% |
| Arthralgia |
1.5% |
| Arthritis |
1.5% |
| Colitis |
1.5% |
| Contraception |
1.5% |
| Cough |
1.5% |
| Diarrhoea |
1.5% |
| Oedema Peripheral |
1.5% |
|
| Vomiting |
15.4% |
| Neuropathy Peripheral |
9.2% |
| Renal Failure Acute |
9.2% |
| Tonsillitis |
7.7% |
| Thrombocytopenia |
6.2% |
| Toxic Skin Eruption |
6.2% |
| Overdose |
4.6% |
| Pruritus |
4.6% |
| Rash Maculo-papular |
4.6% |
| Thrombocytopenic Purpura |
4.6% |
| Cytolytic Hepatitis |
3.1% |
| Drug Intolerance |
3.1% |
| Intracranial Haematoma |
3.1% |
| Nuclear Magnetic Resonance Imaging Abnormal |
3.1% |
| Pulmonary Embolism |
3.1% |
| Renal Failure |
3.1% |
| Swelling Face |
3.1% |
| Vertigo |
3.1% |
| Anaemia |
1.5% |
| Coagulopathy |
1.5% |
|
| Concomitant |
| Ankylosing Spondylitis |
12.6% |
| Product Used For Unknown Indication |
9.3% |
| Rheumatoid Arthritis |
9.3% |
| Chest Pain |
8.9% |
| Drug Use For Unknown Indication |
7.8% |
| Hypertension |
6.3% |
| Multiple Sclerosis |
5.2% |
| Pain |
4.4% |
| Unevaluable Event |
4.4% |
| Analgesic Therapy |
4.1% |
| Prophylaxis |
4.1% |
| Osteoporosis |
3.0% |
| Paraparesis |
3.0% |
| Psoriasis |
3.0% |
| Psoriatic Arthropathy |
3.0% |
| Spondylitis |
2.6% |
| Type 2 Diabetes Mellitus |
2.6% |
| Crohn's Disease |
2.2% |
| Dyspnoea |
2.2% |
| Hepatitis C |
2.2% |
|
| Vomiting |
10.9% |
| Gastric Haemorrhage |
8.7% |
| General Physical Health Deterioration |
6.5% |
| Pulmonary Fibrosis |
6.5% |
| Visual Acuity Reduced |
6.5% |
| Visual Impairment |
6.5% |
| Intermittent Claudication |
4.3% |
| Migraine |
4.3% |
| Osteonecrosis |
4.3% |
| Paresis |
4.3% |
| Pyrexia |
4.3% |
| Rash Maculo-papular |
4.3% |
| Retinal Vein Thrombosis |
4.3% |
| Toxic Skin Eruption |
4.3% |
| Urinary Tract Infection |
4.3% |
| Urticaria |
4.3% |
| Vasculitis Cerebral |
4.3% |
| Angioedema |
2.2% |
| Arthritis Bacterial |
2.2% |
| Cerebral Thrombosis |
2.2% |
|
| Interacting |
| Idiopathic Generalised Epilepsy |
42.9% |
| Antiinflammatory Therapy |
28.6% |
| Arthralgia |
28.6% |
|
| Status Epilepticus |
100.0% |
|
